Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Phase 1

Completed

• Conditions: Healthy
• Interventions: Drug: Atralin (tretinoin) Gel, 0.05%

• Registration Number: NCT00604032
• Lead Sponsor: Coria Laboratories, Ltd.

Brief Summary

To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Primary Completion: 2008-01
• Study First Submitted: 2008-01-16
• Study First Submitted QC: 2008-01-28
• Study First Posted: 2008-01-29
• Status Verified: 2008-02
• Study Completion: 2008-02
• Last Update Submitted: 2008-03-26
• Last Update Posted: 2008-03-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Normal healthy volunteers
• 18 years of age or older

Exclusion Criteria

• Less than 18 years of age

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Atralin (tretinoin) Gel, 0.05%	-

Primary Outcome Measures

Name	Time	Method
UV induced skin sensitization	4 days

Trial Locations

Locations (1)

Suncare Research Laboratories; 🇺🇸 Winston-Salem, North Carolina, United States